A 63-year-old with HFrEF on carvedilol, sacubitril/valsartan, and furosemide asks about an additional mortality-reducing therapy not yet used. eGFR 62...

Question

A 63-year-old with HFrEF on carvedilol, sacubitril/valsartan, and furosemide asks about an additional mortality-reducing therapy not yet used. eGFR 62, K+ 4.2. Which should be added?

Accepted Answer

Spironolactone

Answer

Diltiazem

Answer

Ivabradine despite HR 64 in sinus rhythm

Answer

Verapamil

Answer

Amiodarone

us-abim MCQ (SBA): Heart Failure (HFrEF)

A 63-year-old with HFrEF on carvedilol, sacubitril/valsartan, and furosemide asks about an additional mortality-reducing therapy not yet used. eGFR 62, K+ 4.2. Which should be added?